On Target Laboratories
Cytalux (pafolacianine) is an FDA-approved folate-receptor-targeted fluorescence imaging agent used to help surgeons visualize malignant tissue during cancer surgery, with real-world outcome data now tracking its original clinical-trial findings across more than 1,000 surgeries.
- Country
- United States
Commercial
Cytalux fluorescence agent
Coverage
| CN | EU | US | |
|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Intraoperative molecular diagnostics | diagnostics-medtech | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.